Filing Flows › Camp4 Therapeutics (CAMP) › Q3 2025
Camp4 Therapeutics (CAMP) Q3 2025 earnings results (third quarter 2025)
10-Q filed Nov 6, 2025
Camp4 Therapeutics (CAMP) reported revenue of $795K for the third quarter 2025 (Q3 2025) and -47% from the quarter before.
Camp4 Therapeutics, Q3 2025: revenue $795K, net loss $15.1M, operating cash flow −$11.2M. The chart follows the revenue to costs, profit and cash.
| Q3 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $795K | -47% | — |
| Operating profit | −$13.7M | — | — |
| Net earnings | −$15.1M | — | — |
| Operating cash flow | −$11.2M | — | — |
What changed
Revenue was $795K in Q3 2025, down 47% from the previous quarter.
Operating costs exceeded revenue by $13.7M, an operating margin of -1717.1%. The quarter ended with a net loss of $15.1M, wider than the previous quarter's $12.6M loss.
Operating cash flow was −$11.2M. Non-cash charges added back $416K of depreciation and amortization and $1.0M of share-based compensation. Working capital and other items added $2.5M.
Questions
What was Camp4 Therapeutics' revenue in the third quarter 2025?
Camp4 Therapeutics (CAMP) reported revenue of $795K for the third quarter 2025 (Q3 2025) and -47% from the quarter before.
Source: Camp4 Therapeutics 10-Q on SEC EDGAR.